VANGUARD GROUP INC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$616,297
+26.4%
4,942,230
+4.4%
0.00%
Q4 2022$487,604
-32.3%
4,734,021
-0.0%
0.00%
Q3 2022$720,000
-91.8%
4,735,633
-52.5%
0.00%
Q2 2022$8,772,000
-23.7%
9,967,146
+7.5%
0.00%
Q1 2022$11,493,000
-36.4%
9,268,067
+0.0%
0.00%
Q4 2021$18,066,000
-25.0%
9,264,529
+5.4%
0.00%
-100.0%
Q3 2021$24,077,000
-14.0%
8,787,219
-1.1%
0.00%0.0%
Q2 2021$27,981,000
+126.3%
8,882,942
+53.0%
0.00%
Q1 2021$12,364,000
+95.5%
5,804,419
+78.0%
0.00%
Q4 2020$6,325,000
+366.4%
3,260,631
+67.6%
0.00%
Q3 2020$1,356,000
+120.5%
1,945,067
+66.9%
0.00%
Q2 2020$615,000
+15.8%
1,165,317
-3.5%
0.00%
Q1 2020$531,000
-36.1%
1,206,983
+0.2%
0.00%
Q4 2019$831,000
-35.5%
1,204,5830.0%0.00%
Q3 2019$1,289,000
+48.5%
1,204,583
+0.7%
0.00%
Q2 2019$868,000
-41.5%
1,196,181
+3.1%
0.00%
Q1 2019$1,485,000
+28.2%
1,160,452
+50.3%
0.00%
Q4 2018$1,158,000
+210.5%
771,908
+199.8%
0.00%
Q3 2018$373,000
+51.0%
257,465
+42.7%
0.00%
Q2 2018$247,000
+51.5%
180,375
+3.0%
0.00%
Q1 2018$163,000
+150.8%
175,145
+329.8%
0.00%
Q3 2017$65,000
-5.8%
40,750
+10.1%
0.00%
Q2 2017$69,000
-10.4%
37,027
-5.4%
0.00%
Q1 2017$77,000
-45.0%
39,159
+4.0%
0.00%
Q4 2016$140,00037,6590.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$32,135,00011.34%
VR Adviser, LLC 16,047,286$43,970,0005.65%
COMMODORE CAPITAL LP 5,123,509$14,038,0003.70%
Ghost Tree Capital, LLC 2,000,000$5,480,0001.60%
EPIQ PARTNERS, LLC 916,100$2,510,0001.16%
SILVERARC CAPITAL MANAGEMENT, LLC 707,733$1,939,0001.10%
SPHERA FUNDS MANAGEMENT LTD. 3,824,938$10,480,0000.88%
HighVista Strategies LLC 438,239$1,201,0000.80%
Nicholas Investment Partners, LP 2,786,354$7,635,0000.56%
NEA Management Company, LLC 16,302,596$44,669,0000.53%
View complete list of VISTAGEN THERAPEUTICS INC shareholders